GLP-1 RAs Reduce Suicidal Behavior in Adolescents
Study found a 33% drop in suicidal ideation and attempts, with effect lasting up to 3 years. Medscape Medical News
Does BMI Underestimate Breast Cancer Risk?
Hormone receptor stratification showed that differences in population-attributable risk fractions by body fat were only observed in hormone receptor–positive cases. Medscape Medical News
Two women talk about their diagnoses during breast cancer awareness month to inspire others
October is breast cancer awareness month and highlights a troubling increase of diagnoses in women under 50. Early Today’s Fredlyn Pierre Louis spoke with two women who wanted to share their stories to inspire others.
Statin therapy reduces radiation-induced cardiotoxicity in patients with breast cancer receiving radiotherapy
1. In a cohort of individuals with invasive ductal carcinoma (IDC) that underwent breast-conserving surgery (BCS) and adjuvant breast radiotherapy, the use of statins was associated with a decreased risk of major adverse cardiovascular events (MACE). 2. All statins were effective at reducing the risk of MACE; however, hydrophilic statins (specifically rosuvastatin and pravastatin) had
The post Statin therapy reduces radiation-induced cardiotoxicity in patients with breast cancer receiving radiotherapy first appeared on 2 Minute Medicine. Source: 2 Minute Medicine
Study suggests around 40% of postmenopausal hormone positive breast cancers are linked to excess body fat
Around 40% of postmenopausal hormone positive breast cancer cases may be linked to excess body fat, suggests Spanish research published online in the Journal of Epidemiology & Community Health.
Obesity Epidemic Peaked? FDA Reviews Menopause Drug; Metabolic Surgery and Cancer
(MedPage Today) — The obesity epidemic may be plateauing in the U.S.; this could be why. (Washington Post)
A cohort study of older adults with an initial fragility fracture showed that less than a third filled a prescription for anti-osteoporosis…
Distant Recurrence Risk in Early Breast Cancer on the Decline
(MedPage Today) — The long-term risk of distant recurrence for women with early breast cancer has declined significantly, a decades-long analysis of clinical trial data showed, largely a result of patients enrolling with lower-risk disease along…
FDA says compounding pharmacies can keep making weight-loss med tirzepatide, for now
Pharmacists may continue making compounded versions of the weight-loss medication tirzepatide while the U.S. Food and Drug Administration revisits its Oct. 2 decision to remove the medicine from a national drug shortage list.
The importance of breast cancer screening
October is Breast Cancer Awareness Month. Breast cancer is the second-leading cause of cancer deaths in women across the U.S. And rates of the disease continue to climb, notably among younger women. A report from the American Cancer Society calculates that one in 50 women will develop invasive breast cancer by the age of 50.
Experimental drug RK-33 shows promise in treating breast cancer bone metastasis
In a new study led by Johns Hopkins Medicine, the drug RK-33 has demonstrated promise in treating breast cancer that has spread to the bone (breast cancer bone metastasis). RK-33 was previously shown to help treat other types of cancer and viral illnesses.